Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea
2023-11-13 08:00
Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability
2023-11-10 20:00
Shaping Global Policy: IFPA's Psoriatic Disease Response Index in the Western Pacific
2023-11-10 19:18
H2U Secures Strategic Investment from InnoTherapy as Recognition from Seoul Clinical Laboratories (SCL)
2023-11-10 17:48
MVR-T3011 IV, Global First Intravenous Oncolytic Product, Successfully Concludes Phase I Clinical Study in the U.S. with Outstanding Safety Results
2023-11-10 08:00
PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration following Dose Level 1 Safety Data
2023-11-09 21:00
Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases
2023-11-09 15:05
Noah Launches "Play The Full Game" Campaign with Singaporean Football Legend Fandi Ahmad as Brand Ambassador
2023-11-09 14:31
West Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets
2023-11-09 12:58
DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells
2023-11-09 08:15
Dr. Jinzi J. Wu Presents at the 10th International Workshop on HBV Cure 2023
2023-11-09 08:10
Telix to Present at Jefferies London Healthcare Conference 2023
2023-11-09 04:51
Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema at American Academy of Ophthalmology
2023-11-08 23:23
Porton Advanced Announces a Strategic Partnership with BioMap, with AI Models Facilitating AAV Gene Therapy Development
2023-11-08 22:31
Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region
2023-11-08 13:00
Docquity Expands Digitized Patient Access Programs To Enhance Healthcare Outcomes in Thailand
2023-11-08 10:00
WuXi Biologics Receives AAA MSCI ESG Rating
2023-11-08 08:30
Antengene to Host 2023 R&D Day and Discuss Key Data with KOLs
2023-11-08 08:30
Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
2023-11-08 02:01
Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
2023-11-07 21:58
1
68
69
70
71
72
413